Community/Retail

A flu vaccine is especially important this year, as it can prevent a “twindemic” with COVID-19.

A recent nationwide survey of 400 pharmacists conducted by the American Pharmacists Association (APhA) found that more than three-fourths of pharmacists plan to be vaccinated with 1 of the coronavirus disease 2019 (COVID-19) vaccines.

Although most people say they will receive a COVID-19 vaccine once it becomes available, 27% were unsure.

Study indicates pure CBD was able to reduce cell viability in 3 of the 6 cell lines and that this effect was cell line specific rather than specific to certain cancers.

In recent years, digital health devices have offered pathways for patients to record and send data, which may ultimately encourage the patient to be more interactive in their disease management.

According to the survey results, 56% of patients with chronic obstructive pulmonary disease reported that COVID-19 has made it difficult for them to receive treatment

Proteases are important to the health and viability of cells and viruses. If proteases are inhibited, cells cannot perform many important functions, such as replication.

The treatment of mental illness has long been a quandary for medical professionals throughout history. But historically, mental illness has been more loosely defined than it is today.

Following authorization allowing pharmacists to administer childhood vaccines, some pediatricians have expressed concerns that this deprives children of medical care or could lead to missed vaccines.

Despite the COVID-19 pandemic, several promising drugs are expected to hit the market in late 2020 and early 2021.

Glucose levels should be screened at herpes zoster diagnosis.

Beta-blockers could be used as a potential treatment for COVID-19, according to a study by Italian and Australian researchers.

Further, the findings suggest that cancer survivors are also likely to be at an increased risk of severe coronavirus disease 2019 (COVID-19) outcomes, given that both influenza and COVID-19 are both epidemic respiratory viruses.

Warning letters requested that companies immediately stop selling these unapproved products and said consumers concerned about COVID-19 should talk to their health care provider.

Xolair provides an alternative to surgery or steroids for the treatment of nasal polyps in adults.

Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.

The COVID-19 mRNA vaccine, BNT162b2, developed by Pfizer and BioNTech, has been granted a temporary authorization for emergency use against COVID-19 in the United Kingdom.

The connection between COVID-19 and sleep apnea cannot be explained by obesity rates alone.

In an interview with Pharmacy Times, Bruce Mueller, PharmD, interim dean and professor of clinical pharmacy at the University of Michigan College of Pharmacy, said pharmacists are essential in providing the correct dosing to patients with kidney disease.

Pharmacy Times® interviewed Chad Landmon, JD, of Axinn, Veltrop & Harkrider, on the arguments presented to the Supreme Court on whether a legislative change to the Affordable Care Act makes the law unconstitutional.

Are you curious about what other pharmacists earn? About the job satisfaction and compensation of pharmacists in other geographic areas? So are we!

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

In the digital age, exponential technologies are converging and transforming how we engage in health care.

Device uses an Apple Watch to deliver gentle vibrations to users suffering from post-traumatic stress disorder.

Even when all 5 factors were optimally controlled, patients with type 2 diabetes still had a 21% higher risk for CVD and a 31% higher risk for heart failure hospitalization compared to patients without diabetes.

Moderna intends to submit the EUA application today and believes that the FDA’s Vaccines and Related Biological Products Advisory Committee will meet to review the safety and efficacy data package on Thursday, December 17, according to the press release.

Patients with COVID-19 faced a significant emotional and financial burden after discharge from treatment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.